Angler Gaming levererade ett Q1’26 som var klart starkare än väntat, där bolaget visade sitt första ...
* Q1 adj. EBITDA in line with FactSet consensus * Expect limited consensus estimate revisions * Valu...
Solwers reported its results for Q1 with sales of EUR 21.
Redeye provides an initial take following Paxman’s Q1 2026 report.
Siljansvik has agreed to acquire a 51% stake in Kalmar Energi Försäljning AB at an enterprise valuat...
Redeye comments on GiG Software’s Q1-results where revenue was in line with our expectations while r...
Actic has acquired Ego Hälsostudio, a family-run gym chain with eight facilities in Sundsvall, with ...
Surgical Science demonstrated a solid Q1 which prompted a reasonable share price reaction.
* Sales 0% vs cons (2% organic growth), adj. EBITA +1% vs cons * North America and Europe better, Ot...
Xplora's Q1 revenue came in at NOK 376m in a seasonally weak quarter, 3% lower than consensus.
Redeye comments on Cantargia's first quarter report 2026.
Fastighetsbolaget Trianons förvaltningsresultat per aktie ökade med 20 procent under det första kvar...
Rosenbauer published its Q1 figures, marked by double-digit improvements in top-line and bottom-line...
InvesteraMera ger en kommentar på licensavtalet för Idefirix mellan Hansa Biopharma och SERB Pharmac...
Hoenle published its Q2 FY25/26 results (covering Jan–Mar 2026) yesterday.
The report was below our estimates on sales, but we found ourselves above analyst consensus, which Q...
Kvartalet var något bättre än väntat på omsättning men något svagare vad gäller lönsamhet.
Redeye returns with a comment after the conference call on the EUR115m licensing deal yesterday.
* Volume growth in coming quarters * Growing verticals will likely add some costs * EV/EBIT of 10x '...
Redeye leaves a comment following ExpreS2ion’s announcement of updated Phase I progress and refineme...